InsidersTradesSigma
Follow the 以岭药业 share price and the full insider trade history of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 以岭药业 has recorded 3 insider filings. Market capitalisation: €27.6bn. The latest transaction was filed on 5 May 2023 (Sale). Among the most active insiders: 张秋莲. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
以岭药业是一家健康和制药领域的公司，在 XSHE 市场上市。该公司专注于中药和现代药物的研发。